Navigation Links
Elite Skier Uses OmniPod(R) Insulin Management System at World Championships

Kris Freeman Joins Growing Ranks of Professional Athletes Who Use the OmniPod System to Manage their Diabetes

BEDFORD, Mass., Feb. 18 /PRNewswire-FirstCall/ -- Kris Freeman, one of the country's top professional cross-country skiers, is competing on behalf of the US in the Skiing World Championships this month. As a world-class athlete, Freeman intends to medal, but he has already faced a more daunting challenger: Type I diabetes. Diabetes doesn't keep Freeman from performing at the top of his sport, thanks in part to the OmniPod(R) Insulin Management System, a revolutionary insulin infusion system with no tubing.

"As a professional athlete, I can't afford to worry about my diabetes when I'm competing, and with the OmniPod, I don't have to," said Freeman. "The OmniPod's innovative, tubing-free design is durable enough for the toughest conditions I face during competition. And off the slopes, it gives me freedom to live an active, healthy life, while maintaining great control of my diabetes."

Freeman, the number one Nordic distance skier in the United States, is already a twelve-time national champion, three-time Olympian, and the second most successful American cross-country skier of all time. In 2003, less than three years after his diagnosis with diabetes, Freeman became the first American to ever win the Under 23 World Championships and followed that success with a fourth place finish in the Cross-Country World Championships. In 2004, Freeman finished sixth and fifth in two consecutive World Cups, the best finish by an American in 20 years, and became the first American ever to be ranked in the top 20.

Freeman isn't the only professional athlete to enjoy the freedom of the OmniPod System and its innovative design. Other top athletes who use the OmniPod include:

  • Triathlete Jay Hewitt
  • Mountaineer Lisa Seaman
  • Team Type 1, a team of professional cyclists who have diabetes
  • Dolphin Trainer Robyn Cox

About the OmniPod Insulin Management System

The OmniPod(R) Insulin Management System is the first and only continuous insulin delivery system of its kind on the market. The OmniPod System offers people living with insulin-requiring diabetes all the benefits of insulin pump therapy, with unprecedented freedom, comfort and ease in managing their diabetes. Unlike conventional insulin pumps, the OmniPod System has no tubing and features automated, virtually pain-free insertion. It has just two, wireless components: the Pod - a, compact, lightweight, self-adhesive insulin delivery device that is worn discreetly on the skin beneath clothing; and the Personal Diabetes Manager - a wireless, menu-driven, hand-held device that programs the Pod.

About Insulet Corporation

Insulet Corporation (Nasdaq: PODD) is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-requiring diabetes. Founded in 2000, Insulet is based in Bedford, MA.


    Rachel Kessler, Lazar Partners
    (917) 660-0608

SOURCE Insulet Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The Oscars, Parties Spur Cosmetic Surgery Quick Fixes with Hollywoods Elite...
2. Local Chiropractic Doctor Graduates from Elite Whiplash Trauma Training Program Led by International Scientific Authority, Dr. Arthur Croft
3. Wins Bronze in HSMAI'S Annual Adrian Awards Competition
4. Elite Meetings International Names New Advisory Board
5. Announces Commission-Free Policy Comprehensive Search and RFP Engine Now Provides Net Rates for Groups
6. MINRAD International, Inc. Announces Termination of RxElite Holdings Inc. as Anesthetics Distributor for the Human Market in United States
7. MINRAD International, Inc. Announces Change in Distribution Agreement with RxElite Holdings, Inc.
8. UAB joins elite brain cancer research group
9. Injury Patterns Similar for Circus Artists, Elite Athletes
10. China Yingxia International, Inc. Retains CCG Elite
11. Dynatronics Introduces New Synergie Elite Aesthetic Line
Post Your Comments:
(Date:11/24/2015)... , ... November 24, 2015 , ... In an ... restrictions and variables that determine which patients are or are not eligible for bariatric ... have a BMI over 40, are more than 100 pounds overweight, or have a ...
(Date:11/24/2015)... UT (PRWEB) , ... November 24, 2015 , ... It ... Magazine. For a business, it is critical that the first impression be positive and ... they are not likely to buy anything or want to return. They will also ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... gather to share their knowledge and experiences at a live taping of the ... Ruesch Center for the Cure of Gastrointestinal Cancers 2015 Symposium at Georgetown University ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... Aided by ... today announced an innovative study designed to yield insights into how to detect and ... of biomarkers for pancreatic cancer from small, non-coding RNA molecules (ncRNA), genetic material that ...
(Date:11/24/2015)... ... November 24, 2015 , ... Sir Grout of Baltimore is ... certification. The award recognizes good companies for excellence in service and a commitment ... and hard surface restoration company earned this recognition after a thorough review by ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... November 24, 2015 F1000Workspace - ... - since it was launched just six months ago. ... and authoring platform for scientists - since it was launched ... have been loaded on to F1000Workspace - a ... since it was launched just six months ago. ...
(Date:11/24/2015)... YORK , Nov. 24, 2015 iRhythm Technologies, ... advancing cardiac care, today announced that it will participate in the ... Hotel in New York, NY . ... present on Tuesday December 1, 2015 at 8:50am ET. ... . --> . ...
(Date:11/24/2015)... uptake of recently approved and pipeline premium products for Type 1 Diabetes ... says GBI Research . --> The ... Mellitus (T1DM), will be a key driver of market growth to 2021, ... The uptake of recently approved and pipeline premium products for Type 1 ... 2021, says GBI Research . Type ...
Breaking Medicine Technology: